Pfizer UK removes sales incentives for anti-infectives
The move comes under the firm’s commitment to fight antimicrobial resistance
Read Moreby Selina McKee | Sep 27, 2019 | News | 0
The move comes under the firm’s commitment to fight antimicrobial resistance
Read Moreby Anna Smith | May 2, 2019 | News | 0
The results showed revenue growth across all three of GSK’s divisions.
Read Moreby Selina McKee | Jan 31, 2019 | News | 0
Novartis has announced a rise of 5% in net sales in 2018, bringing the net total to $51.9 billion.
Read Moreby Selina McKee | Apr 25, 2018 | News | 0
GlaxoSmithKline has booked a 2 percent dip in revenues for the first quarter to £7.2 billion, after results were hit by a “significant currency impact” and lower sales of prescription drugs.
Read Moreby Selina McKee | Feb 8, 2018 | News | 0
GlaxoSmithKline has reported a sales hike of 3 percent at constant exchange rates (CER*) for 2017, after growth was recorded across all of its three global businesses.
Read Moreby Selina McKee | Oct 27, 2016 | News | 0
GlaxoSmithKline has posted a 23 percent leap in sales to £7.5 billion for the third quarter, while core operating profit jumped 35 percent to £2.3 billion, beating expectations.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
